Recent advances and global trends in breast reconstruction: narrative review
Breast Communications · 2025
DOI: 10.21037/bc-25-20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Communications, 2025. Verfasst von Yoshihiro Sowa und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background and Objective: The global rise in breast cancer incidence and the growing demand for cosmetic breast augmentation have accelerated innovation in breast reconstruction. We aim to synthesize the latest advances and worldwide trends across surgical, biomaterial, regenerative, and digital domains up to mid-2025 in a narrative review.
Methods
A targeted PubMed search (English, human studies, 2000.1.1–2025.4.5) identified clinical trials, cohorts, case series, systematic reviews/meta-analyses, and technology assessments on autologous flaps, autologous fat grafting (AFG), implant-based and prepectoral reconstruction, biomaterials/regenerative medicine, and medical artificial intelligence (AI). Reference lists were hand-searched. Key Content and Findings: Contemporary techniques covered include perforator-based autologous reconstruction [deep inferior epigastric perforator (DIEP) as the current standard; profunda artery perforator (PAP), superior gluteal artery perforator (S-GAP), and other alternatives], supported by enabling technologies such as sensory neurotization, indocyanine-green perfusion imaging, and emerging robot-assisted microsurgery. AFG is widely adopted for contour refinement, partial and total reconstruction, and as an adjunct to flaps/implants; it yields high patient satisfaction with generally favorable safety, but often requires multiple sessions and may necessitate imaging clarification of fat necrosis. Implant-based reconstruction benefits from fifth-generation devices, yet capsular contracture and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) remain key concerns; responses include micro/nanotextured surfaces and antimicrobial strategies. Prepectoral placement reduces animation deformity and capsular contracture relative to subpectoral approaches, with comparable overall complications, though rippling and patient selection remain challenges and long-term data are evolving. Regenerative approaches [adipose derived stem cells: ADSC-enhanced grafting, resorbable/three-dimensional (3D)-printed scaffolds] and decision-support technologies (AI-driven planning, 3D symmetry assessment, and tools such as individualized decision aids) are expanding personalization, while evidence gaps (external validation, standardized outcomes, device registries) persist. Hybrid and “tribrid” combinations (flap, AFG and implants) broaden options within multidisciplinary, patient-centered pathways.
Conclusions
Breast reconstruction is converging on personalized, evidence-informed care that integrates advanced microsurgery, AFG, safer implants, prepectoral techniques, and regenerative/AI-enabled planning. Priorities include multicenter prospective studies, standardized patient reported outcome (PRO) and 3D metrics, robust post-market surveillance for implants/scaffolds, and equitable access to decision aids and enabling technologies to inform clinical guidelines and policy.
Zitieren
APA
Sowa, Y., Nakayama, I., Shimizu, Y., Higai, S., Kyono, K., & Kurokawa, Y. (2025). Recent advances and global trends in breast reconstruction: narrative review. Breast Communications. https://doi.org/10.21037/bc-25-20
Vancouver
Sowa Y, Nakayama I, Shimizu Y, Higai S, Kyono K, Kurokawa Y. Recent advances and global trends in breast reconstruction: narrative review. Breast Communications. 2025. doi:10.21037/bc-25-20
BibTeX
@article{Sowa2025,
author = {Sowa, Yoshihiro and Nakayama, Ichiro and Shimizu, Yusuke and Higai, Shino and Kyono, Kaori and Kurokawa, Yasue},
title = {Recent advances and global trends in breast reconstruction: narrative review},
journal = {Breast Communications},
year = {2025},
doi = {10.21037/bc-25-20}
}
EUVIMED